Labcorp CEO awarded 58,470 performance shares

LABCORP HOLDINGS INC.

Accepted by SEC EDGAR 03/30/2026 - 12:58 PM EDT

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

LABCORP HOLDINGS INC. President & CEO Adam H. Schechter received a grant of 58,470 shares of Common Stock on March 26, 2026, as a performance award tied to results for the three-year period ended December 31, 2025. To cover related tax obligations, 26,106 shares of Common Stock were withheld at $268.38 per share rather than sold in the open market. After these compensation and tax-withholding entries, Schechter directly holds 113,137 shares of Common Stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Schechter Adam H

Role President & CEO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	58,470	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	26,106	$268.38	$7.01M

Holdings After Transaction: Common Stock — 113,137 shares (Direct)

Footnotes (2)

F1. Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025.
F2. Stock withholding to satisfy tax withholding obligations.

Key Figures

Performance shares granted: 58,470 shares Tax withholding shares: 26,106 shares Withholding reference price: $268.38 per share +2 more

5 metrics

Performance shares granted 58,470 shares Common Stock grant on March 26, 2026

Tax withholding shares 26,106 shares Withheld to satisfy tax obligations

Withholding reference price $268.38 per share Value used for tax withholding shares

Post-transaction holdings 113,137 shares Common Stock directly owned after transactions

Performance period end December 31, 2025 Three-year performance period for the award

Key Terms

performance award, three-year period, tax withholding obligations, Common Stock, +1 more

5 terms

performance award financial

"pursuant to a performance award granted on February 7, 2023"

three-year period financial

"relating to performance during the three-year period ended December 31, 2025"

tax withholding obligations financial

"Stock withholding to satisfy tax withholding obligations"

Common Stock financial

"security_title: Common Stock for both transactions"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

non-derivative financial

"transaction_type: non-derivative for both entries"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Labcorp (LH) CEO Adam Schechter report in this Form 4 filing?

Adam Schechter reported a performance-based share award and related tax withholding. He received 58,470 shares of Labcorp Common Stock, with 26,106 shares withheld to satisfy tax obligations. Following these entries, his direct Common Stock holdings total 113,137 shares.

How many Labcorp (LH) shares were granted to the CEO in this transaction?

The CEO received 58,470 shares of Labcorp Common Stock at no purchase price. The award was granted pursuant to a performance award originally approved on February 7, 2023, based on performance over the three-year period ended December 31, 2025.

Why were 26,106 Labcorp (LH) shares disposed of in this Form 4?

The 26,106 shares were withheld to satisfy tax withholding obligations, not sold in the market. These shares were valued at $268.38 per share for tax purposes, reflecting a standard mechanism to pay taxes on equity compensation using shares.

What are Adam Schechter’s Labcorp (LH) holdings after this Form 4?

After the performance share award and tax withholding, Adam Schechter directly owns 113,137 shares of Labcorp Common Stock. This figure reflects his updated position following both the grant of 58,470 shares and the withholding of 26,106 shares for taxes.

Is this Labcorp (LH) Form 4 a market purchase or sale by the CEO?

No, the filing reflects compensation and tax withholding events rather than open-market trades. Schechter received 58,470 performance-based shares at no cost, and 26,106 shares were withheld to cover taxes, a common non-market mechanism for equity awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schechter Adam H

(Last)

(First)

(Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON

NORTH CAROLINA

27215

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/26/2026		A⁽¹⁾		58,470	A	$0	139,243	D
Common Stock	03/26/2026		F⁽²⁾		26,106	D	$268.38	113,137	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025.

2. Stock withholding to satisfy tax withholding obligations.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Adam H. Schechter	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR